Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
Clinical trial NCT02767557 · COMPLETED
Trial details
- NCT number
- NCT02767557
- Sponsor
- Herlev Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2021-08-12
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.